Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
KDR genetic predictor of toxicities induced by sorafenib and regorafenibThe Pharmacogenomics Journal, Published online: 2022-04-28; doi:10.1038/s41397-022-00279-32022-04-28 DOI: 10.1038/s41397-022-00279-3
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Point of care CYP2C19 genotyping after percutaneous coronary interventionThe Pharmacogenomics Journal, Published online: 2022-04-21; doi:10.1038/s41397-022-00278-42022-04-21 DOI: 10.1038/s41397-022-00278-4
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United StatesThe Pharmacogenomics Journal, Published online: 2022-04-18; doi:10.1038/s41397-022-00277-52022-04-18 DOI: 10.1038/s41397-022-00277-5
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysisThe Pharmacogenomics Journal, Published online: 2022-04-01; doi:10.1038/s41397-022-00275-72022-04-01 DOI: 10.1038/s41397-022-00275-7
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare dataThe Pharmacogenomics Journal, Published online: 2022-03-31; doi:10.1038/s41397-022-00276-62022-03-31 DOI: 10.1038/s41397-022-00276-6
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Combining familial hypercholesterolemia and statin genetic studies as a strategy for the implementation of pharmacogenomics. A multidisciplinary approachThe Pharmacogenomics Journal, Published online: 2022-03-31; doi:10.1038/s41397-022-00274-82022-03-31 DOI: 10.1038/s41397-022-00274-8